Status:
COMPLETED
Oxytocin and Social Cognition in Frontotemporal Dementia
Lead Sponsor:
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Collaborating Sponsors:
The Alzheimer Society London and Middlesex
Conditions:
Frontotemporal Dementia
Pick's Disease
Eligibility:
All Genders
30-80 years
Phase:
NA
Brief Summary
Investigations into the components of cognition damaged in frontotemporal dementia (FTD) demonstrate that patients with FTD show deficits in facial and verbal expression recognition, lack insight into...
Eligibility Criteria
Inclusion
- Clinical diagnosis of probable Frontotemporal Dementia or Pick's disease
- Caregiver available to participate in all study visits
Exclusion
- Severe language or memory deficits that preclude completion of the cognitive tasks
- Females who are pregnant or breastfeeding (a pregnancy test will be done on females who have not completed menopause)
- Uncontrolled hypertension
- Bradycardia (rate \<50 bpm) or tachycardia (rate \> 100 bpm)
- Current use of prostaglandins
- Use of any investigational or experimental drug or device within the last 60 days prior to screening or within 5 half-lives of the experimental drug , whichever is longer
Key Trial Info
Start Date :
September 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2010
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT01002300
Start Date
September 1 2009
End Date
November 1 2010
Last Update
March 18 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cognitive Neurology and Alzheimer's Research Centre, St. Joseph's Hospital
London, Ontario, Canada, N6A 3T8